Related Experiment Videos
Oxidative phosphorylation diseases and cerebellar ataxia
J M Shoffner1, A Kaufman, D Koontz
1Department of Genetics and Molecular Medicine, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Clinical Neuroscience (New York, N.Y.)
|January 1, 1995
Summary
Mitochondrial DNA (mtDNA) mutations, including rearrangements and point mutations, can cause oxidative phosphorylation (OXPHOS) diseases. This review details OXPHOS disorders linked to mtDNA mutations where cerebellar ataxia is a prominent symptom.
Area of Science:
- Genetics
- Biochemistry
- Neurology
Background:
- Oxidative phosphorylation (OXPHOS) diseases arise from genetic defects in nuclear or mitochondrial DNA (mtDNA).
- mtDNA mutations encompass large rearrangements (deletions/duplications) and point mutations in tRNA, rRNA, or OXPHOS polypeptide genes.
- While numerous mtDNA mutations exist, only a subset are linked to cerebellar ataxia.
Purpose of the Study:
- To review the clinical, biochemical, and genetic characteristics of OXPHOS diseases.
- To focus on OXPHOS disorders caused by mtDNA mutations presenting with cerebellar ataxia.
Main Methods:
- Literature review of genetic mutations affecting OXPHOS.
- Analysis of clinical, biochemical, and genetic data from relevant studies.
- Synthesis of information on mtDNA mutations associated with cerebellar ataxia.
Main Results:
- Over 30 pathogenic mtDNA point mutations and 60+ mtDNA deletion types are documented.
- A specific subset of these mtDNA mutations is associated with cerebellar ataxia.
- Clinical, biochemical, and genetic features vary among these OXPHOS diseases.
Conclusions:
- mtDNA mutations are a significant cause of OXPHOS diseases with ataxia.
- Understanding these genetic and clinical features is crucial for diagnosis and management.
- Further research is needed to elucidate the mechanisms linking specific mtDNA mutations to cerebellar ataxia.